• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Eurosurveillance: Uptake and impact of a new live attenuated influenza vaccine programme in England: early results of a pilot in primary school-age ch

tetano

Editor, Senior Moderator
Eurosurveillance, Volume 19, Issue 22, 05 June 2014
Surveillance and outbreak reports
Uptake and impact of a new live attenuated influenza vaccine programme in England: early results of a pilot in primary school-age children, 2013/14 influenza season
R G Pebody ()1, H K Green1, N Andrews1, H Zhao1, N Boddington1, Z Bawa1, H Durnall2, N Singh1, A Sunderland1, L Letley1, J Ellis1, A J Elliot1, M Donati1, G E Smith1, S de Lusignan2,3, M Zambon1

Public Health England, United Kingdom
Royal College of General Practitioners Research and Surveillance Unit, Birmingham, United Kingdom
University of Surrey, Guildford, United Kingdom

Citation style for this article: Pebody RG, Green HK, Andrews N, Zhao H, Boddington N, Bawa Z, Durnall H, Singh N, Sunderland A, Letley L, Ellis J, Elliot AJ, Donati M, Smith GE, de Lusignan S, Zambon M. Uptake and impact of a new live attenuated influenza vaccine programme in England: early results of a pilot in primary school-age children, 2013/14 influenza season. Euro Surveill. 2014;19(22):pii=20823. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20823
Date of submission: 12 May 2014

As part of the introduction and roll-out of a universal childhood live-attenuated influenza vaccination programme, 4?11 year-olds were vaccinated in seven pilot areas in England in the 2013/14 influenza season. This paper presents the uptake and impact of the programme for a range of disease indicators. End-of-season uptake was defined as the number of children in the target population who received at least one dose of influenza vaccine. Between week 40 2013 and week 15 2014, cumulative disease incidence per 100,000 population (general practitioner consultations for influenza-like illness and laboratory-confirmed influenza hospitalisations), cumulative influenza swab positivity in primary and secondary care and cumulative proportion of emergency department respiratory attendances were calculated. Indicators were compared overall and by age group between pilot and non-pilot areas. Direct impact was defined as reduction in cumulative incidence based on residence in pilot relative to non-pilot areas in 4?11 year-olds. Indirect impact was reduction between pilot and non-pilot areas in <4 year-olds and >11 year-olds. Overall vaccine uptake of 52.5% (104,792/199,475) was achieved. Although influenza activity was low, a consistent, though not statistically significant, decrease in cumulative disease incidence and influenza positivity across different indicators was seen in pilot relative to non-pilot areas in both targeted and non-targeted age groups, except in older age groups, where no difference was observed for secondary care indicators.

full article


http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20823
 
Back
Top Bottom